These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32149959)

  • 1. Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort.
    Lazenby GB; Hill A; Tarleton J; Soper D
    Sex Transm Dis; 2020 May; 47(5):332-337. PubMed ID: 32149959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.
    Davis A; Dasgupta A; Goddard-Eckrich D; El-Bassel N
    Sex Transm Dis; 2016 Oct; 43(10):617-22. PubMed ID: 27631355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.
    Getaneh FW; Oliveira CR; Pathy S; Sheth SS
    Am J Obstet Gynecol; 2023 Sep; 229(3):284.e1-284.e10. PubMed ID: 37393012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
    Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS
    J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and risk factors for
    Ijasan O; Okunade KS; Oluwole AA
    Niger Postgrad Med J; 2018; 25(1):21-26. PubMed ID: 29676341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional analysis of
    Bochner AF; Baeten JM; Rustagi AS; Nakku-Joloba E; Lingappa JR; Mugo NR; Bukusi EA; Kapiga S; Delany-Moretlwe S; Celum C; Barnabas RV;
    Sex Transm Infect; 2017 Nov; 93(7):520-529. PubMed ID: 28377421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection.
    Mason PR; Fiori PL; Cappuccinelli P; Rappelli P; Gregson S
    Epidemiol Infect; 2005 Apr; 133(2):315-23. PubMed ID: 15816157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women.
    Lazenby GB; Thompson L; Powell AM; Soper DE
    Sex Transm Dis; 2019 Jan; 46(1):2-8. PubMed ID: 30067546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs.
    Miller M; Liao Y; Gomez AM; Gaydos CA; D'Mellow D
    J Infect Dis; 2008 Feb; 197(4):503-9. PubMed ID: 18275272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
    Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
    Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women.
    Price CM; Peters RPH; Steyn J; Mudau M; Olivier D; De Vos L; Morikawa E; Kock MM; Medina-Marino A; Klausner JD
    Sex Transm Dis; 2018 May; 45(5):332-336. PubMed ID: 29465686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
    Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
    Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.
    Muzny CA; Burkholder GA; Fry KR; Austin EL; Schwebke JR
    Sex Transm Dis; 2016 Aug; 43(8):483-8. PubMed ID: 27419815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
    Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
    Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.